Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Host Hotels & Resorts
HST
$15.9B
| $1.2M | 0.01% |
67,856
-334,600
| -83% | -$5.77M |
|
1052
Rigetti Computing
RGTI
$5.46B
| $1.2M | 0.01% |
54,304
+45,325
| +505% | +$1.48M |
|
1053
Buckle
BKE
$2.29B
| $1.2M | 0.01% |
22,445
-73,421
| -77% | -$4.09M |
|
1054
Sprouts Farmers Market
SFM
$8.03B
| $1.19M | 0.01% |
14,990
-99,084
| -87% | -$8.89M |
|
1055
Golar LNG
GLNG
$5.25B
| $1.19M | 0.01% |
32,065
-30,655
| -49% | -$1.17M |
|
1056
F&G Annuities & Life
FG
$3.03B
| $1.19M | 0.01% |
38,660
+5,220
| +16% | +$163K |
|
|
BBT
1057
Beacon Financial Corp
BBT
$2.65B
| $1.19M | 0.01% |
45,183
-90,547
| -67% | -$2.29M |
|
|
CRCL
1058
CALL
Circle Internet Group
CRCL
$22.3B
| $1.19M | 0.01% |
+15,000
| New | +$1.55M |
|
1059
AnaptysBio
ANAB
$1.73B
| $1.18M | 0.01% |
+24,431
| New | +$952K |
|
1060
JPMorgan Chase
JPM
$947B
| $1.18M | 0.01% |
3,670
-1,702
| -32% | -$527K |
|
1061
Par Pacific Holdings
PARR
$3.72B
| $1.18M | 0.01% |
+33,604
| New | +$1.34M |
|
|
TPH
1062
DELISTED
Tri Pointe Homes
TPH
| $1.18M | 0.01% |
37,506
-15,309
| -29% | -$498K |
|
1063
Teck Resources
TECK
$34.4B
| $1.18M | 0.01% |
24,562
+2,241
| +10% | +$97.1K |
|
1064
Schrodinger
SDGR
$1.4B
| $1.17M | 0.01% |
65,640
+39,232
| +149% | +$744K |
|
1065
Barclays
BCS
$90.7B
| $1.17M | 0.01% |
46,093
-60,103
| -57% | -$1.33M |
|
1066
XPEL
XPEL
$1.39B
| $1.17M | 0.01% |
+23,497
| New | +$982K |
|
1067
CALL
Ally Financial
ALLY
$12.9B
| $1.17M | 0.01% |
25,800
| – | – |
|
|
1068
PUT
Ally Financial
ALLY
$12.9B
| $1.17M | 0.01% |
25,800
| – | – |
|
1069
National Bank Holdings
NBHC
$1.86B
| $1.17M | 0.01% |
30,723
-17,848
| -37% | -$672K |
|
|
PPLT
1070
abrdn Physical Platinum Shares ETF
PPLT
$2.24B
| $1.17M | 0.01% |
+62,600
| New | +$965K |
|
1071
Cognizant
CTSH
$28B
| $1.16M | 0.01% |
14,005
-63,686
| -82% | -$4.76M |
|
1072
Entera Bio
ENTX
$592M
| $1.16M | 0.01% |
596,585
+29,629
| +5% | +$69.5K |
|
1073
Synopsys
SNPS
$75.5B
| $1.16M | 0.01% |
+2,461
| New | +$1.09M |
|
|
DMIIU
1074
Drugs Made In America Acquisition II Corp Unit
DMIIU
| $1.14M | 0.01% |
113,527
-16,473
| -13% | -$165K |
|
|
AEXA
1075
American Exceptionalism Acquisition Corp
AEXA
$571M
| $1.14M | 0.01% |
99,786
-67,750
| -40% | -$761K |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.